In primary murine microglia, AIM2 has been shown to alleviate the damaging neuroinflammation seen in the experimental autoimmune encephalitis (EAE) model of multiple sclerosis (MS), and other mouse models of AD and PD (219–221). This evidence concerns the gene AIM2 and Parkinson disease.